BioMS Medical Announces 2009 Year End Results Canada NewsWire (press release) The decrease in expenses was the net result of: completion of the MAESTRO-01 clinical trial and discontinuation of other trials; cost recoveries for ...
Blood Vessels Bounce Back Once Smokers Quit BusinessWeek The study included more than 1500 people taking part in a clinical trial to help them quit smoking. Before and one year after the participants stopped ...
TiGenix says needs extra study for key drug in US Interactive Investor "The path will be longer than anticipated, but we believe that our eight years of clinical trial experience with ChondroCelect will help us to remain at the ...
BioMS Medical Announces 2009 Year End Results Trading Markets (press release) The decrease in expenses was the net result of: completion of the MAESTRO-01 clinical trial and discontinuation of other trials; cost recoveries for ...
FDA critiques Medtronic's MRI-compatible pacemaker NorthJersey.com "We worked closely with the FDA in the design of our clinical trial and exceeded the minimum number of required trial participants," said company spokesman ...
ACC: Novel Anticoagulant Seems Safe and Effective MedPage Today Lars Wallentin, MD, PhD, of the Uppsala Clinical Research Center, in Uppsala, Sweden, said that while the safety of betrixaban was impressive at 40 mg, ...
Newer Blood Thinner Beats Plavix for Bypass Patients U.S. News & World Report For the study, Held and colleagues looked at a subgroup of 1261 patients in the Platelet Inhibition and Patient Outcomes (PLATO) trial. ...
U.S. Stocks Are Quiet After Hours Investor's Business Daily Clinical trial manager Parexel International (PRXL) gapped up to a 4% gain in big volume. The stock's fourth straight advance put it at its highest level ...
New Combo Drug May Cut Blood Pressure WebMD At the dosage chosen for further clinical trials, 200 milligrams, LCZ696 dropped systolic blood pressure (the top number) by 11 points and diastolic blood ...